ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: Furiex

Takeda, Furiex await FDA approval decision on diabetes drug Nesina

Takeda, Furiex await FDA approval decision on diabetes drug Nesina

April 25, 2012 1:32 pm by | 1 Comments

Today we might glimpse the U.S. Food and Drug Administration’s thoughts on approving new type 2 diabetes drugs in a post-Avandia world.Nesina, a Takeda Pharmaceutical (TYO:4502) compound licensed from Furiex ... Read more
Furiex statin drug candidate fails in phase 2 clinical trial

Furiex statin drug candidate fails in phase 2 clinical trial

December 9, 2011 12:08 pm by | 0 Comments

An investigational statin drug being developed by Furiex Pharmaceuticals (NASDAQ:FURX) has failed in phase 2 clinical trials, ending an attempt to produce what the company hoped would become an alternative ... Read more
Takeda, Furiex try again in a post-Avandia diabetes drug world

Takeda, Furiex try again in a post-Avandia diabetes drug world

July 26, 2011 4:55 pm by | 0 Comments

A type 2 diabetes drug hopefully thought of as a potential blockbuster before stalling amid safety concerns is now taking another shot at approval.Takeda Pharmaceuticals (TYO:4502), which is partnered with ... Read more